Jorge A. García

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text

Medicine, Oncology, Urology +15

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci et al. · Journal of Clinical Oncology · 2018 · 1.1K citations · Full text

Medicine, Oncology, Urology +17

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Andrew J. Armstrong, Susan Halabi, Tim Eisen et al. · The Lancet Oncology · 2016 · 424 citations

Medicine, Oncology, Cancer Pharmacology +13

Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Homayoun Zargar, Patrick Espiritu, Adrian Fairey et al. · European Urology · 2014 · 297 citations

Medicine, Oncology, Urology +13

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Brian I. Rini, Tanya B. Dorff, Paul Elson et al. · The Lancet Oncology · 2016 · 254 citations · Full text

Medicine, Nephrology, Oncology +14